Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$108,333.00

Toward a valid rat model of alcohol use disorder in schizophrenia: Brain reward circuit dysfunction and effects of alcohol and clozapine

EF 2014-15

Résumé
Alcohol use disorder (AUD) occurs commonly in patients with schizophrenia (SCZ) and dramatically worsens their clinical course. AUD in patients with SCZ is associated with poor response to treatment, as well as treatment non-compliance, psychotic relapse, violence and suicide. Green (mentor) and colleagues have suggested that there may be an underlying brain reward circuit (BRC) dysfunction that results in AUD in patients with SCZ, and that alcohol use may transiently ameliorate this deficit. Unfortunately, very few treatment options are available for the treatment of co-occurring AUD and schizophrenia. Although the atypical antipsychotic clozapine (CLOZ) can reduce alcohol use in patients with schizophrenia, CLOZ's toxicity severely limits its use in patients. The mechanism of CLOZ's action toward reducing alcohol drinking in patients with SCZ is not known, but our group has suggested that CLOZ may reduce alcohol drinking by correcting the dysfunctional BRC. In order to create new CLOZ-like medications for AUD in SCZ, a valid animal model of BRC dysfunction in co-occurring AUD and SCZ is required. This proposal seeks to further validate a novel rat model of AUD in SCZ by studying the BRC and the effects of alcohol drinking and of CLOZ on this circuit in the neonatal ventral hippocampal lesion (NVHL) rat, a well-established rat model of schizophrenia. Using functional magnetic resonance imaging, we will assess resting state functional connectivity between regions in the BRC (i.e. nucleus accumbens [region of interest] and prefrontal cortex) prior to alcohol drinking, and either after established alcohol drinking or after CLOZ treatment. These data will advance our neurobiologic formulation of the BRC dysfunction underlying AUD in patients with SCZ. Ultimately, these findings will help expedite the design of new CLOZ-like agents that can decrease alcohol use in patients with SCZ, thereby reducing the healthcare burden associated with such difficult-to-treat patients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
New Hampshire, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
319235
Name
Khokhar Jibran Y
Region
New Hampshire
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Toward a valid rat model of alcohol use disorder in schizophrenia: Brain reward circuit dysfunction and effects of alcohol and clozapine
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$108,333
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Addiction; Alcohol; Neuroimaging; Schizophrenia
Abstract
Alcohol use disorder (AUD) occurs commonly in patients with schizophrenia (SCZ) and dramatically worsens their clinical course. AUD in patients with SCZ is associated with poor response to treatment, as well as treatment non-compliance, psychotic relapse, violence and suicide. Green (mentor) and colleagues have suggested that there may be an underlying brain reward circuit (BRC) dysfunction that results in AUD in patients with SCZ, and that alcohol use may transiently ameliorate this deficit. Unfortunately, very few treatment options are available for the treatment of co-occurring AUD and schizophrenia. Although the atypical antipsychotic clozapine (CLOZ) can reduce alcohol use in patients with schizophrenia, CLOZ's toxicity severely limits its use in patients. The mechanism of CLOZ's action toward reducing alcohol drinking in patients with SCZ is not known, but our group has suggested that CLOZ may reduce alcohol drinking by correcting the dysfunctional BRC. In order to create new CLOZ-like medications for AUD in SCZ, a valid animal model of BRC dysfunction in co-occurring AUD and SCZ is required. This proposal seeks to further validate a novel rat model of AUD in SCZ by studying the BRC and the effects of alcohol drinking and of CLOZ on this circuit in the neonatal ventral hippocampal lesion (NVHL) rat, a well-established rat model of schizophrenia. Using functional magnetic resonance imaging, we will assess resting state functional connectivity between regions in the BRC (i.e. nucleus accumbens [region of interest] and prefrontal cortex) prior to alcohol drinking, and either after established alcohol drinking or after CLOZ treatment. These data will advance our neurobiologic formulation of the BRC dysfunction underlying AUD in patients with SCZ. Ultimately, these findings will help expedite the design of new CLOZ-like agents that can decrease alcohol use in patients with SCZ, thereby reducing the healthcare burden associated with such difficult-to-treat patients.
Competitiondate
201411
Approvedterm2
2 yrs 2 mths
Pinamesdelim
Khokhar, Jibran Y
Approvedterm
2 ans 2 mois
Cihrcontribution2
~ $108,333~ $0~